International Journal of Cancer

Cover image for Vol. 138 Issue 3

Editor-in-Chief: Professor Peter Lichter, DKFZ, Germany

Impact Factor: 5.085

ISI Journal Citation Reports © Ranking: 2014: 31/211 (Oncology)

Online ISSN: 1097-0215

Recently Published Issues

See all

Read the Latest from IJC

New Content from IJC

IJC Accepted Articles(accepted manuscripts)
Accepted Articles have been accepted for publication in IJC, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.

IJC Early View(e-pub ahead of print)
Early View articles are definitive in format and presented in advance of print publication.

Professor Lichter's Top Picks

Read Now

Editor's Choice from IJC

Access the monthly Editor’s Choice article FREE!

2016 (Volume 138)

Janaury (Issue 1)

Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
Kwai Fung Hui et al (pages 125–136)

2015 (Volume 137)

December (Issue 12)

Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer
Diederick Duijvesz et al (pages 2869–2878)

December (Issue 11)

The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia
Radoslav Mladenov et al (pages 2729-2738)

November (Issue 10)

Selective depletion of tumor neovasculature by microbubble destruction with appropriate ultrasound pressure
Junfen Wang et al. (pages 2478-2491)

November (Issue 9)

Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus
Il-Kyu Cho et al. (Pages 2253–2269)

October (Issue 8)

ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors
Ping Zhang et al. (Pages 2007–2018)

October (Issue 7)

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans
S. Bramante et al. (Pages 1775–1783)

October (Issue 6)

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting
D. Martorelli et al. (Pages 1374–1385)

September (Issue 5)

NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases
L. Sadegh et al. (Pages 1085 – 1094)

Click the button for

Editors' Choice

2014 Joint IJC & Klaus Tschira Stiftung Lectureships

IJC Lectureships

The Joint IJC and Klaus Tschira Stiftung Lectureship at the German Cancer Research Center (DKFZ) in Heidelberg honors three to four leading scientists in the field of cancer research each year. We would like to offer our international readership a taste of these lectures and now present the 2014 videos. Additional videos will be posted following each lecture. We welcome you to view them. The videos from the lectures in 2012 and 2013 can be found under “Special Features”.

Prof Jane Visvader
The Walter and Eliza Hall Institute Melbourne, Australia


Prof Peter W. Laird
University of Southern California, School of Medicine, CA


Prof Dr C. Richard Boland
Baylor University Medical Center Dallas, Texas